Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (338)	4/15/2002 1:04:50 PM
From: Jibacoa	Read Replies (1) of 544

INGN is moving up today after closing last week's up-gap.<g> siliconinvestor.com At the recent annual meeting of AACR they reported that results of two Phase 2 studies on patients receiving higher dose of ADVEXIN gene therapy showed a significant survival advantage when compared to a group of patients in another study receiving a lower dose of the drug.<g> INGN still has resistance at its March 18 H of 5.35 before it can test the December 18 H at 6.74 <g> If it can manage to test its May H at 7.80 or the February 2001 at 8.25 it could be a good % gain from present level.<g> The October 2000 H was 15.50 <g> siliconinvestor.com The float is less than 8 M. Institutions have been buying and it still has enough cash to go for another two years at the present burn rate.<g> Earnings report is due on April 30. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next